Idorsia Ltd is reaching out for more - We have more ideas, we see more opportunities, and we want to help more patients.
In order to achieve this, we will develop Idorsia into one of Europe’s leading biopharmaceutical companies, with a strong scientific core.
Headquartered in Switzerland - a European biotech hub - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team, a fully-functional research center, and a strong balance sheet – the ideal constellation to bring R&D efforts to business success.
Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 600 highly qualified specialists dedicated to realizing our ambitious targets.
Cllnical Pharmacologist - CD 1802
Lead and/or contribute to multiple phase I/IIa studies, ensuring study deliverables are met on time, on budget, and with the appropriate quality.
Contribute to selection of, negotiation with, and supervision of CROs.
Write and/or organize the writing and/or review of study-related documents. Work in close collaboration with the Clinical Pharmacology Modeling and Simulation group to include the appropriate related components in the study protocol. Contribute to the writing of the clinical sections of regulatory documents.
Contribute to the preparation of submission documents to IRB/IEC and health authorities and answer all scientific/medical inquiries from IRB/IEC and/or health authorities.
Develop a comprehensive understanding of the science related to a study and/or project and provide appropriate training in the medical/scientific aspects of the study to the appropriate persons.
In collaboration with operational staff manage monitoring aspects of the study including but not limited to initiation visit, first dosing, and database lock activities.
Responsible for the medical review of study data prior to database lock.
Responsible for all aspects of study protocols, reports, project summaries, and development plans regarding regulatory requirements.
Interpret and present study results to Life Cycle Team, Development Team, and committees comprising members of Idorsia Senior Leadership.
Perform literature reviews and write scientific publications when required.
Provide expertise to the PK/PD section of protocol of phase llb-IV studies.
Follow relevant quality control procedures to verify that the quality requirements for the trial-related activities are fulfilled.
A minimum master’s degree level of education in a relevant scientific subject with a preference for PhD or MD level of education.
At least 2 years’ clinical research experience, leading or contributing to the scientific aspects of Phase I/IIa clinical trials within a pharmaceutical, biotech or CRO organization.
We have a strong preference for candidates who can demonstrate recent authorship or contribution to scientific publications.
Experience with pharmacokinetic (PK)/pharmacodynamic (PD) evaluation techniques.
Ability to handle and oversee multiple tasks simultaneously and to prioritize in a high-pace environment.
Excellent organizational ability and flexibility with a keen attention to details.
Highly self-motivated and proactive with a scientific and pragmatic approach to problem solving.
A team-player with well-developed interpersonal and communication skills; able to communicate effectively with internal and external contact persons in complex matrix organizations.
Very good English knowledge (oral/written).
What Idorsia offers
Exciting opportunities for development and professional growth within our dynamic organization.
A collaborative and solution-oriented environment where you can make a difference.
An innovative and open culture in a truly multicultural environment.
A competitive salary and generous social benefits.
If you are interested, please send your CV and motivation letter by email to firstname.lastname@example.org clearly stating the job title and reference of the position to which you are applying in the subject line.
Please be informed that if you are selected for this position, your employment will be subject to a pre-employment background screening process, of which you would be informed in greater detail in due course.
Please note Idorsia operates a strictly-controlled list of preferred recruitment partners. For those partners who have no valid, signed Master Service Agreement in place with Idorsia all unsolicited resumes, CVs, anonymous profiles, or any other candidate details submitted through our website or to personal e-mail accounts of employees of Idorsia Pharmaceuticals (including any of its subsidiaries, affiliates or related companies) are considered the property of Idorsia Pharmaceuticals and are not subject to payment of any form of introduction, placement or referral fees.